Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 40-54, January 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sneider, T. W.
Right arrow Articles by Morris, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sneider, T. W.
Right arrow Articles by Morris, H. P.

Enzymes of Thymidine Triphosphate Synthesis in Selected Morris Hepatomas1 ,2

Thomas W. Sneider, Van R. Potter and Harold P. Morris3

McArdle Memorial Laboratory, The Medical School, University of Wisconsin, Madison, Wisconsin 53706

The activities of certain enzymes catalyzing reactions leading to the synthesis of thymidine triphosphate were analyzed in vitro in minimal deviation type Morris hepatomas of normal karyotype as well as in Novikoff and Reuber H-35 cells from tissue culture and in Ehrlich ascites cells. Most Morris hepatomas had normal or near-normal levels of deoxycytidine monophosphate deaminase, while Novikoff and Ehrlich cells and rat thymus and bone marrow showed extreme elevations in activity of this enzyme. The Novikoff, H-35, and Ehrlich ascites cells, and all of the Morris hepatomas except 9633, had elevated deoxythymidine monophosphate (dTMP) synthetase activity. All of the hepatomas and tissue culture material exhibited elevations in deoxythymidine (TdR) kinase and possibly dTMP kinase activities. Hepatomas 5123C, 7800, and 9618A possessed the ability to degrade thymine at lesser rates than normal adult rat liver, while hepatoma 9633 and Novikoff and H-35 cells from tissue culture apparently lacked thymine degradative ability. With the exception of dTMP synthetase, the activities of these enzymes in normal karyotype Morris hepatomas showed no quantitative relationship with growth rate. Among the hepatomas and enzymes reported, TdR kinase was the only enzyme with consistently elevated activity. These results and certain unpublished data are discussed with respect to possible alternative routes to deoxythymidine triphosphate synthesis and the chemotherapy of cancer.

1 This work was supported in part by Grant No. P-448 from the American Cancer Society, by USPHS Grant No. TO1-CA-5002 from the National Cancer Institute, and by USPHS Grant No. CA-10729. A preliminary report was given before the American Association for Cancer Research in Chicago, Illinois, in April 1967 (50).

2 This paper is the fifth in a series entitled The Comparative Enzymology and Cell Origin of Rat Hepatomas.

3 Laboratory of Biochemistry, National Cancer Institute, NIH, Bethesda, Maryland 20014. Present address: Department of Biochemistry, College of Medicine, Howard University, Washington, D. C. 20001. Supported in part by USPHS Grant No. CA-10729.

Received 2/23/68. Accepted 9/ 5/68.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.